Cencora Inc (COR)

$332.71 +4.15 (1.26%)
Market Cap 63.70B
Revenue (ttm) 293.96B
Net Income (ttm) 1.51B
EPS (ttm) N/A
PE Ratio 21.36
Forward PE 19.04
Profit Margin 0.51%
Debt to Equity Ratio 3.73
Volume 911,800
Avg Vol 1,427,372
Day's Range N/A - N/A
Shares Out 193.88M
Stochastic %K 92%
Beta 0.63
Analysts Strong Sell
Price Target $339.71

Company Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management...

Industry: Medical Distribution
Sector: Healthcare
Phone: 610 727 7000
Address:
1 West First Avenue, Conshohocken, United States
DanaBlack
DanaBlack Oct. 24 at 6:06 PM
$CAH gonna make money nice and quietly to myself over here 😂 not leaving until it’s at $MCK and $COR prices!
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 23 at 4:34 AM
Enter: $COR NOV 21 2025 $340 CALLS Buy in Price: $6.60 - $8.20 Take Profit: $15.91 Stop Bleeding: $5.81 ROI Potential: 141% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 3:49 AM
Enter: $COR NOV 21 2025 $330 CALLS Buy in Price: $8.50 - $9.70 Take Profit: $20.23 Stop Bleeding: $7.48 ROI Potential: 138% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 21 at 9:16 PM
$COR Share Price: $328.84 Contract Selected: Feb 20, 2026 $330 Calls Buy Zone: $16.15 – $19.95 Target Zone: $30.26 – $36.99 Potential Upside: 77% ROI Time to Expiration: 121 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 2:04 AM
Enter: $COR NOV 21 2025 $330 CALLS Buy in Price: $8.80 - $9.50 Take Profit: $19.80 Stop Bleeding: $7.74 ROI Potential: 125% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 19 at 1:02 AM
Enter: $COR NOV 21 2025 $330 CALLS Buy in Price: $8.80 - $9.50 Take Profit: $21.21 Stop Bleeding: $7.74 ROI Potential: 141% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 18 at 5:31 AM
Enter: $COR NOV 21 2025 $330 CALLS Buy in Price: $8.80 - $9.20 Take Profit: $11.35 Stop Bleeding: $7.74 ROI Potential: 29% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 16 at 1:16 PM
Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $12.73 - $13.80 Take Profit: $19.73 Stop Bleeding: $11.20 ROI Potential: 55% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
JarvisFlow
JarvisFlow Oct. 16 at 1:12 PM
Mizuho has updated their rating for Cencora ( $COR ) to Outperform with a price target of 334.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 15 at 7:09 AM
Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $11.45 - $12.70 Take Profit: $19.58 Stop Bleeding: $10.08 ROI Potential: 71% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
Latest News on COR
IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

Oct 16, 2025, 9:00 AM EDT - 9 days ago

IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

Oct 14, 2025, 12:47 PM EDT - 11 days ago

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

MCK WFC

Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release

Oct 6, 2025, 4:30 PM EDT - 18 days ago

Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release

Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 10, 2025, 2:05 PM EDT - 6 weeks ago

Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 9, 2025, 6:02 PM EDT - 6 weeks ago

Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript

Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 5, 2025, 11:11 AM EDT - 7 weeks ago

Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

Aug 27, 2025, 4:15 PM EDT - 2 months ago

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap

Aug 12, 2025, 2:31 PM EDT - 2 months ago

Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap

Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy

Aug 8, 2025, 5:08 PM EDT - 2 months ago

Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy

Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript

Aug 6, 2025, 12:25 PM EDT - 2 months ago

Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript

Cencora raises annual profit forecast on strong demand for specialty drugs

Aug 6, 2025, 7:51 AM EDT - 2 months ago

Cencora raises annual profit forecast on strong demand for specialty drugs

Cencora Reports Fiscal 2025 Third Quarter Results

Aug 6, 2025, 6:30 AM EDT - 2 months ago

Cencora Reports Fiscal 2025 Third Quarter Results

Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release

Jul 3, 2025, 7:30 AM EDT - 4 months ago

Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release

Cencora Elects Lori J. Ryerkerk to Its Board of Directors

May 28, 2025, 7:30 AM EDT - 5 months ago

Cencora Elects Lori J. Ryerkerk to Its Board of Directors

Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs

May 16, 2025, 8:37 AM EDT - 5 months ago

Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs

Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings

May 7, 2025, 2:06 PM EDT - 6 months ago

Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings

Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript

May 7, 2025, 10:55 AM EDT - 6 months ago

Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript

Cencora Reports Fiscal 2025 Second Quarter Results

May 7, 2025, 6:30 AM EDT - 6 months ago

Cencora Reports Fiscal 2025 Second Quarter Results

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

Apr 4, 2025, 3:42 PM EDT - 7 months ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

CVS MCK PM

These 15 stocks are the most profitable companies in the S&P 500

Mar 31, 2025, 7:35 AM EDT - 7 months ago

These 15 stocks are the most profitable companies in the S&P 500

AAPL ABBV AON BA CL CLX DVA

Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

Mar 28, 2025, 7:00 AM EDT - 7 months ago

Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

Cencora: Higher Potential Returns After Reduced Walgreens Stake

Feb 26, 2025, 11:00 AM EST - 8 months ago

Cencora: Higher Potential Returns After Reduced Walgreens Stake

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Feb 6, 2025, 8:37 PM EST - 9 months ago

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds

Feb 6, 2025, 8:30 PM EST - 9 months ago

Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds

WBA

Cencora Reinforces Efforts to Strengthen Pharmaceutical Supply Chain with Expansion of Drug Shortages Mitigation Program

Feb 6, 2025, 8:30 AM EST - 9 months ago

Cencora Reinforces Efforts to Strengthen Pharmaceutical Supply Chain with Expansion of Drug Shortages Mitigation Program

Cencora (COR) Q1 2025 Earnings Call Transcript

Feb 5, 2025, 11:40 AM EST - 9 months ago

Cencora (COR) Q1 2025 Earnings Call Transcript

Cencora raises 2025 profit forecast on specialty drug demand

Feb 5, 2025, 7:23 AM EST - 9 months ago

Cencora raises 2025 profit forecast on specialty drug demand

Cencora Reports Fiscal 2025 First Quarter Results

Feb 5, 2025, 6:30 AM EST - 9 months ago

Cencora Reports Fiscal 2025 First Quarter Results

Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients

Jan 27, 2025, 7:30 AM EST - 9 months ago

Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients

HROW

Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth

Jan 13, 2025, 12:07 PM EST - 10 months ago

Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth

COST DHR EL MSGS WST

Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release

Jan 8, 2025, 7:30 AM EST - 10 months ago

Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release

Cencora raises annual profit forecast

Jan 2, 2025, 4:23 PM EST - 10 months ago

Cencora raises annual profit forecast

Cencora Completes Acquisition of Retina Consultants of America

Jan 2, 2025, 4:15 PM EST - 10 months ago

Cencora Completes Acquisition of Retina Consultants of America

Cencora Closes $1.8 Billion Senior Notes Offering

Dec 9, 2024, 4:15 PM EST - 11 months ago

Cencora Closes $1.8 Billion Senior Notes Offering

Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers

Dec 6, 2024, 8:30 AM EST - 11 months ago

Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers

Cencora: Competitive Advantages Defined

Dec 5, 2024, 10:26 AM EST - 11 months ago

Cencora: Competitive Advantages Defined

Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035

Dec 2, 2024, 10:49 PM EST - 11 months ago

Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035

Cencora to Host Inaugural Product Showcase

Nov 26, 2024, 8:30 AM EST - 11 months ago

Cencora to Host Inaugural Product Showcase

Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings

Nov 6, 2024, 11:38 AM EST - 1 year ago

Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings

Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript

Nov 6, 2024, 10:56 AM EST - 1 year ago

Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript

Cencora to buy Retina Consultants of America for $4.6 bln

Nov 6, 2024, 6:54 AM EST - 1 year ago

Cencora to buy Retina Consultants of America for $4.6 bln

Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results

Nov 6, 2024, 6:35 AM EST - 1 year ago

Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results

Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America

Nov 6, 2024, 6:30 AM EST - 1 year ago

Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America

Cencora Expands Enterprise Leadership Team with Two Senior Appointments

Nov 4, 2024, 8:30 AM EST - 1 year ago

Cencora Expands Enterprise Leadership Team with Two Senior Appointments

Dividend Aristocrats Of The Future - Part 3

Nov 1, 2024, 4:42 PM EDT - 1 year ago

Dividend Aristocrats Of The Future - Part 3

AIZ COST CSX DUK K RSG SRE

Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release

Oct 1, 2024, 7:30 AM EDT - 1 year ago

Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release

Cencora Supports Pharmaceutical Supply Chain Education with Two New Programs for Health System Pharmacy Residents

Sep 10, 2024, 8:30 AM EDT - 1 year ago

Cencora Supports Pharmaceutical Supply Chain Education with Two New Programs for Health System Pharmacy Residents

Cencora Elects Frank Clyburn to Its Board of Directors

Aug 15, 2024, 7:30 AM EDT - 1 year ago

Cencora Elects Frank Clyburn to Its Board of Directors

Intelliguard, Cencora Partner to Increase Compatibility of RFID-Tagged Medications, Medication Management Systems

Aug 14, 2024, 9:00 AM EDT - 1 year ago

Intelliguard, Cencora Partner to Increase Compatibility of RFID-Tagged Medications, Medication Management Systems

Walgreens continues to shed stake in Cencora as it looks to bolster turnaround

Aug 2, 2024, 1:59 PM EDT - 1 year ago

Walgreens continues to shed stake in Cencora as it looks to bolster turnaround

WBA

DanaBlack
DanaBlack Oct. 24 at 6:06 PM
$CAH gonna make money nice and quietly to myself over here 😂 not leaving until it’s at $MCK and $COR prices!
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 23 at 4:34 AM
Enter: $COR NOV 21 2025 $340 CALLS Buy in Price: $6.60 - $8.20 Take Profit: $15.91 Stop Bleeding: $5.81 ROI Potential: 141% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 3:49 AM
Enter: $COR NOV 21 2025 $330 CALLS Buy in Price: $8.50 - $9.70 Take Profit: $20.23 Stop Bleeding: $7.48 ROI Potential: 138% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 21 at 9:16 PM
$COR Share Price: $328.84 Contract Selected: Feb 20, 2026 $330 Calls Buy Zone: $16.15 – $19.95 Target Zone: $30.26 – $36.99 Potential Upside: 77% ROI Time to Expiration: 121 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 2:04 AM
Enter: $COR NOV 21 2025 $330 CALLS Buy in Price: $8.80 - $9.50 Take Profit: $19.80 Stop Bleeding: $7.74 ROI Potential: 125% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 19 at 1:02 AM
Enter: $COR NOV 21 2025 $330 CALLS Buy in Price: $8.80 - $9.50 Take Profit: $21.21 Stop Bleeding: $7.74 ROI Potential: 141% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 18 at 5:31 AM
Enter: $COR NOV 21 2025 $330 CALLS Buy in Price: $8.80 - $9.20 Take Profit: $11.35 Stop Bleeding: $7.74 ROI Potential: 29% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 16 at 1:16 PM
Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $12.73 - $13.80 Take Profit: $19.73 Stop Bleeding: $11.20 ROI Potential: 55% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
JarvisFlow
JarvisFlow Oct. 16 at 1:12 PM
Mizuho has updated their rating for Cencora ( $COR ) to Outperform with a price target of 334.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 15 at 7:09 AM
Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $11.45 - $12.70 Take Profit: $19.58 Stop Bleeding: $10.08 ROI Potential: 71% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 14 at 7:17 AM
Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $11.04 - $11.80 Take Profit: $24.62 Stop Bleeding: $9.72 ROI Potential: 123% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 13 at 7:51 PM
Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $12.50 - $13.12 Take Profit: $28.50 Stop Bleeding: $11.00 ROI Potential: 128% Exit Within: 1 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 13 at 7:56 AM
Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $10.90 - $12.50 Take Profit: $17.77 Stop Bleeding: $9.59 ROI Potential: 63% Exit Within: 78 Minutes https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 12 at 5:40 AM
Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $10.90 - $12.50 Take Profit: $17.77 Stop Bleeding: $9.59 ROI Potential: 63% Exit Within: 78 Minutes https://moneygroup.us/alerts
0 · Reply
Doozio
Doozio Oct. 11 at 2:58 PM
$MCK appears like a $COR holding 🐒🍌🧠⏰♾️
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 11 at 4:46 AM
Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $10.90 - $12.50 Take Profit: $17.77 Stop Bleeding: $9.59 ROI Potential: 63% Exit Within: 78 Minutes https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 10 at 1:45 AM
Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $8.00 - $9.70 Take Profit: $13.60 Stop Bleeding: $7.04 ROI Potential: 70% Exit Within: 138 Minutes https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 9 at 6:00 AM
Enter: $COR NOV 21 2025 $320 CALLS Buy in Price: $7.50 - $7.90 Take Profit: $14.55 Stop Bleeding: $6.60 ROI Potential: 94% Exit Within: 92 Minutes https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 8 at 3:43 AM
Enter: $COR NOV 21 2025 $310 CALLS Buy in Price: $10.34 - $12.40 Take Profit: $14.58 Stop Bleeding: $9.10 ROI Potential: 41% Exit Within: 101 Minutes https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 7 at 12:05 AM
Enter: $COR NOV 21 2025 $310 CALLS Buy in Price: $10.34 - $10.60 Take Profit: $21.82 Stop Bleeding: $9.10 ROI Potential: 111% Exit Within: 292 Minutes https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 5 at 10:04 AM
Enter: $COR NOV 21 2025 $310 CALLS Buy in Price: $10.34 - $10.70 Take Profit: $24.71 Stop Bleeding: $9.10 ROI Potential: 139% Exit Within: 189 Minutes https://moneygroup.us/alerts
0 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 3:43 PM
$COR: Unusual Options Activity Alerted CALL flow observed 13x contracts at Strike price of $310 Exp on 01/15/2027 with Premium of $59K and showing NEUTRAL Sentiment
0 · Reply